SUPRIYA LIFESCIENCE
|
SUPRIYA LIFESCIENCE Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 11.16 | 18.86 | 16.89 | 50.15 | 26.93 |
| CEPS(Rs) | 12.63 | 20.12 | 17.81 | 10.90 | 6.13 |
| DPS(Rs) | 0.60 | 0.60 | 0.54 | 10.00 | - |
| Book NAV/Share(Rs) | 86.91 | 76.50 | 36.70 | 101.93 | 64.08 |
| Tax Rate(%) | 27.23 | 26.75 | 26.13 | 23.72 | 30.96 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 24.87 | 36.36 | 40.18 | 27.36 | 20.05 |
| EBIT Margin(%) | 24.52 | 35.93 | 39.77 | 28.67 | 20.96 |
| Pre Tax Margin(%) | 23.91 | 35.21 | 38.82 | 26.76 | 17.77 |
| PAT Margin (%) | 17.40 | 25.80 | 28.68 | 20.41 | 12.27 |
| Cash Profit Margin (%) | 19.69 | 27.51 | 30.25 | 22.19 | 13.96 |
| Performance Ratios | |||||
| ROA(%) | 11.56 | 25.73 | 31.61 | 24.90 | 15.82 |
| ROE(%) | 13.66 | 34.34 | 59.17 | 60.42 | 53.11 |
| ROCE(%) | 18.72 | 43.34 | 60.12 | 49.67 | 36.52 |
| Asset Turnover(x) | 0.66 | 1.00 | 1.10 | 1.22 | 1.29 |
| Sales/Fixed Asset(x) | 1.95 | 3.40 | 3.63 | 3.45 | 3.38 |
| Working Capital/Sales(x) | 1.40 | 1.48 | 3.61 | 8.44 | -143.11 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.51 | 0.29 | 0.28 | 0.29 | 0.30 |
| Receivable days | 70.62 | 58.51 | 53.35 | 57.07 | 64.39 |
| Inventory Days | 73.53 | 51.10 | 51.64 | 40.70 | 35.46 |
| Payable days | 114.26 | 93.20 | 143.03 | 123.24 | 106.71 |
| Valuation Parameters | |||||
| PER(x) | 17.08 | 26.13 | - | - | - |
| PCE(x) | 15.10 | 24.50 | - | - | - |
| Price/Book(x) | 2.19 | 6.44 | - | - | - |
| Yield(%) | 0.31 | 0.12 | - | - | - |
| EV/Net Sales(x) | 3.02 | 7.09 | -0.01 | 0.31 | 0.37 |
| EV/Core EBITDA(x) | 10.07 | 16.97 | -0.03 | 0.87 | 1.41 |
| EV/EBIT(x) | 11.01 | 17.78 | -0.03 | 0.92 | 1.53 |
| EV/CE(x) | 1.70 | 5.12 | -0.01 | 0.28 | 0.41 |
| M Cap / Sales | 3.33 | 7.48 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | -13.04 | 35.49 | 25.53 | 12.17 | 30.49 |
| Core EBITDA Growth(%) | -37.52 | 24.37 | 62.77 | 50.43 | 138.17 |
| EBIT Growth(%) | -40.12 | 23.37 | 66.27 | 53.10 | 166.98 |
| PAT Growth(%) | -40.81 | 22.83 | 68.38 | 86.19 | 351.70 |
| EPS Growth(%) | -40.81 | 11.69 | -66.32 | 86.19 | 351.70 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.03 | 0.26 | 0.55 | 0.96 |
| Current Ratio(x) | 4.85 | 4.99 | 1.82 | 1.27 | 0.98 |
| Quick Ratio(x) | 3.64 | 4.06 | 1.32 | 0.96 | 0.76 |
| Interest Cover(x) | 40.43 | 50.37 | 42.01 | 15.05 | 6.59 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | - | - | - |
Compare Financial Ratios of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹3,168.5 Cr | 2.8% | -6.7% | 81.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹356,001.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
| CIPLA | ₹108,813.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹100,075.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,325.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹96,553.2 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 2.8% |
-6.7% |
81.4% |
| SENSEX | 0.5% |
1.4% |
23.5% |
You may also like the below Video Courses
